An open-label, multi-center, phase II study of Patupilone (Epo906), in the treatment of recurrent or progressive brain metastases in patients with non-small cell lung cancer (Nsclc) Meeting Abstract


Authors: Nayak, L.; Omuro, A.; DeAngelis, L.; Robins, H. I.; Govindan, R.; Gadgeel, S.; Kelly, K.; Rigas, J.; Reimers, H. J.; Peereboom, D.; Rosenfeld, S.; Garst, J.; Ramnath, N.; Wing, P.; Zheng, M.; Urban, P.; Abrey, L.; Wen, P.
Abstract Title: An open-label, multi-center, phase II study of Patupilone (Epo906), in the treatment of recurrent or progressive brain metastases in patients with non-small cell lung cancer (Nsclc)
Meeting Title: 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)/18th Annual Meeting of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 15
Issue: Suppl. 3
Meeting Dates: 2013 Nov 21-24
Meeting Location: San Francisco, CA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2013-11-01
Start Page: iii122
End Page: iii123
Language: English
ACCESSION: WOS:000327456200492
PROVIDER: wos
DOI: 10.1093/neuonc/not182
Notes: Meeting Abstract: NO-100 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Antonio Marcilio Padula Omuro
    204 Omuro
  2. Lauren E Abrey
    278 Abrey